Learning together: new program aims to help couples face prostate cancer

NCT ID NCT07196488

Recruiting now Symptom relief Sponsor: National Taipei University of Nursing and Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an 8-week program where prostate cancer patients and their spouses learn and support each other using a handbook, a mobile app, and professional guidance. The goal is to improve physical symptoms, emotional well-being, and family resilience. Sixty couples will be randomly assigned to either the program plus usual care or usual care alone, and will complete questionnaires at the start, 10 weeks, and 16 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dyadic Co-learning Intervention (handbook, mobile app, professional support)
What this could lead to: If it works, this could offer a simple, supportive program to help couples cope better with prostate cancer together.
What could go wrong: This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The program is behavioral, not a medical treatment, so it won't directly affect the cancer itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER (ADENOCARCINOMA)

Contacts and locations

Locations

Keelung Chang Gung Memorial Hospital
NOT_YET_RECRUITING

Keelung, Taiwan
LinKou Chang Gung Memorial Hospital
RECRUITING

Taoyuan, 333, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.